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OBJECTIVE—Regional differences among adipose depots in
capacities for fatty acid storage, susceptibility to hypoxia, and
inﬂammation likely contribute to complications of obesity. We
deﬁned the properties of endothelial cells (EC) isolated from
subcutaneous adipose tissue (SAT) and visceral adipose tissue
(VAT) biopsied in parallel from obese subjects.
RESEARCH DESIGN AND METHODS—The architecture and
properties of the fat tissue capillary network were analyzed using
immunohistochemistry and ﬂow cytometry. CD34
/CD31
 EC
were isolated by immunoselection/depletion. Expression of che-
mokines, adhesion molecules, angiogenic factor receptors, as
well as lipogenic and senescence-related genes were assayed by
real-time PCR. Fat cell size and expression of hypoxia-dependent
genes were determined in adipocytes from both fat depots.
RESULTS—Hypoxia-related genes were more highly expressed
in VAT than SAT adipocytes. VAT adipocytes were smaller than
SAT adipocytes. Vascular density and EC abundance were higher
in VAT. VAT-EC exhibited a marked angiogenic and inﬂamma-
tory state with decreased expression of metabolism-related
genes, including endothelial lipase, GPIHBP1, and PPAR gamma.
VAT-EC had enhanced expression of the cellular senescence
markers, IGFBP3 and -H2AX, and decreased expression of
SIRT1. Exposure to VAT adipocytes caused more EC senes-
cence-associated -galactosidase activity than SAT adipocytes,
an effect reduced in the presence of vascular endothelial growth
factor A (VEGFA) neutralizing antibodies.
CONCLUSIONS—VAT-EC exhibit a more marked angiogenic
and proinﬂammatory state than SAT-EC. This phenotype may be
related to premature EC senescence. VAT-EC may contribute to
hypoxia and inﬂammation in VAT. Diabetes 59:2755–2763,
2010
T
he endothelium plays a major role in regulating
the exchange of leukocytes, nutrients, and oxy-
gen between blood and tissues. The extent of the
capillary network and endothelial cell (EC) char-
acteristics are major determinants of growth and function
of adipose tissue (AT) (1). Indeed, angiogenesis and
adipogenesis have been shown, through distinct ap-
proaches, to be tightly linked (2–4). Moreover, lipogenesis
is dependent on lipoprotein lipase (LPL) and the newly
discovered endothelial cell-surface glycoproteins, glyco-
sylphosphatidylinositol-anchored HDL binding protein 1
(GPIHBP1), which are anchored to the EC that line the
luminal surface of capillaries (5,6). Additionally, a recent
study demonstrated that endothelial targeting of peroxi-
some proliferator-activated receptor gamma (PPAR) reg-
ulates the metabolic response to high-fat diet in mice (7).
Little is known about regional variations in the properties
of fat tissue EC. Given their central role in lipid metabo-
lism and inﬂammation, we tested the hypothesis that EC
and their microenvironments differ among human fat
depots in obesity.
We tested our hypothesis by comparing abdominal
subcutaneous to omental EC isolated in parallel from the
same obese human subjects for the following reasons: 1)
These two depots are highly clinically relevant, with
omental fat more heavily implicated in metabolic syn-
drome and adverse clinical consequences of obesity than
subcutaneous fat (8). 2) Omental fat becomes more exten-
sively inﬁltrated with immuno-inﬂammatory cells, includ-
ing macrophages and T-lymphocytes, than subcutaneous
fat in obesity (9–12). 3) More is known about the differ-
ences in metabolism, fatty acid handling, gene expression,
and mechanisms of growth in these two depots in humans
with obesity than most other depots (13,14). 4) These two
depots differ in fat cell size in response to obesity as well
as to lipogenesis and lipolysis (15,16).
We found that EC isolated from omental fat had reduced
expression of genes related to metabolism and increased
expression of genes related to angiogenesis and inﬂamma-
tion compared with subcutaneous cells. Conditioned me-
dium prepared from fat cells of these two depots from
obese subjects have distinct effects on EC from lean
subjects. We found that cellular senescence, a proinﬂam-
matory state, is more evident in omental than subcutane-
ous fat-derived EC, possibly contributing to regional
variations in fat tissue function.
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Materials. Collagenase type 1 was purchased from Worthington Biochemical
(Lakewood, NJ). Kits for CD34
 and CD31
 cells were, respectively, from
StemCell Technologies (Grenoble, France) and Dynal-Biotech (Invitrogen,
Cergy-Pontoise, France). Culture media, including endothelial cell basal
medium (ECBM), were from Promocell (Heidelberg, Germany). Antibodies
for ﬂow cytometry were from BD Biosciences (Le Pont-de-Claix, France) or
Caltag (Invitrogen, Cergy-Pontoise, France). Antibodies for immunoﬂuores-
cence were from Dakocytomation (Denmark, CD31), Epitomics (CD34),
Zymed (Invitrogen, France, ICAM1), Santa-Cruz (Cliniscience, France,
GPIHBP1), Upstate (Millipore, France, phospho-histone--H2AX), and Molec-
ular Probes (Invitrogen; secondary antibodies coupled to AlexaFluor-488 or
AlexaFluor-546). Chemicals were from Sigma (Saint-Quentin-Fallavier,
France).
Subjects and isolation of mature adipocytes, stromal-vascular fraction
cells, and EC from human subcutaneous and visceral AT (SAT and
VAT). Paired biopsies from abdominal SAT (periumbilical) or VAT (greater
omental) were obtained from subjects undergoing bariatric surgery for
obesity. Subjects had been weight stable for at least 3 months before surgery,
and they included 29 women and 1 man (mean BMI  SEM  43.35  1.05
kg/m
2, range 34.5–59.1; mean age  SEM  40.4  1.93 years, range 26–61
years). All subjects gave informed consent. Five subjects were hypertensive,
6 had hypercholesterolemia, and 3 had type 2 diabetes. The mean time since
obesity  SEM had been diagnosed was 18.2  1.4 years. Abdominal SAT were
obtained from 51 nonobese healthy women undergoing plastic surgery for
cosmetic purposes (mean BMI  SEM  23.11  0.221, range 19.5–27.2; mean
age  SEM  43.57  1.753, range 24–74). Fat collection protocols were
approved by the Institutional Research Board of Inserm and the Toulouse
University Hospital Ethics Committee. AT (2–10 g) was processed immedi-
ately after removal. Adipocytes and stromal-vascular fraction (SVF) were
obtained by collagenase digestion as previously described (10). After diges-
tion and ﬁltration of the adipocyte suspension (250-m mesh nylon sieves),
adipocytes were washed three times with Krebs-Ringer bicarbonate buffer
supplemented with 10 mmol/l HEPES (KRBH) and 0.1% fatty acid-free BSA
(pH  7.4). Mature adipocytes were suspended in ECBM supplemented with
0.1% BSA (1/10, vol/vol). Five L of cell suspension were transferred onto
plastic slides. Three different calibrated ﬁelds were examined to measure
adipocyte diameters using NIS software (Nikon, Champigny-sur-Marne,
France). SVF cells were counted and analyzed by ﬂow cytometry to determine
the number of ECs. At least 100,000 cells (in 100-l phosphate buffer saline
[PBS]/0.5% BSA, 2 mmol/l EDTA) were incubated (for 20 min, at 4°C) with
FITC-CD31 and PerCP-CD34 antibodies or the appropriate isotype controls.
After washing, the labeled cells were analyzed by ﬂow cytometry using a
ﬂuorescence-activated cell sorter calibur ﬂow cytometer and Diva software
(BD-Biosciences). When the quantity of SVF cells was sufﬁcient (11 subjects,
paired SAT and VAT), native CD34
/CD31
 cells (EC) were isolated by
immunoselection/depletion as previously described (10). Mature adipocytes
and EC were either lysed and stored at 20°C for mRNA extraction or further
processed.
Mature adipocyte culture. SAT and VAT mature adipocytes were placed in
ﬁbrin gels (1.5 mg ﬁbrinogen/ml ECBM supplemented with 25 units/ml
thrombin; 1/3, vol/vol) and cultured in ECBM/0.1% BSA supplemented with
100 units/ml penicillin and 100 g/ml streptomycin. After 24 h, the adipocyte-
conditioned media were collected and frozen at 80°C.
SAT mature adipocytes were cultured in ECBM supplemented with 0.1%
BSA, 100 units/ml penicillin, and 100 g/ml streptomycin in CLINIcell 25-culture
cassettes (1/3, vol/vol) in normoxia or hypoxia chambers (1% O2; Sanyo, Avon,
France). After 24 h, mature adipocytes were lysed and stored at 20°C for
RNA extraction.
Immunohistochemistry analyses. Tissue immunoﬂuorescent staining of
human SAT and VAT cut into small pieces (0.5–1 mm
3) was performed. After
ﬁxation in paraformaldehyde 4% for 1 h and subsequent washing in PBS, AT
pieces were incubated for 30 min in PBS/2% BSA in the presence of 0.1%
Triton. For -H2AX staining, AT pieces were permeabilized for 5 min in 95%
ethanol and 5% acetic acid, and then incubated for 30 min in Tris-buffered
saline (TBS)/3% BSA. AT pieces were incubated for 1 h with primary antibody
(CD31 [1/50], CD34 [1/200], ICAM1 [1/50], GPIHBP1 [1/40], -H2AX [1/200]).
After several washings (PBS/0.2% Tween or TBS), AT pieces were incubated
for 30 min in PBS/2% BSA/0.1% Triton or TBS/3% BSA and then incubated with
the corresponding ﬂuorescently-labeled secondary antibodies (AlexaFluor-
488 or AlexaFluor-546, 1/200). After washing, AT pieces were incubated for 10
min with 10 g/ml Hoescht 33342 to stain nuclei. They were placed between
two mounting slides and examined with a ﬂuorescence (Nikon) or confocal
(Zeiss 510) microscope.
Quantiﬁcation of phospho--H2AX positive nuclei in human SAT and VAT
was performed on three calibrated ﬁelds using NIS software (Nikon,
Champigny-sur-Marne, France) and normalized to the total number of nuclei
(Hoescht 33342 staining).
RNA isolation and real-time PCR. Total RNA was extracted from EC and
mature adipocytes and real-time PCR analyses were performed as previously
described (10). Primers (Taqman gene expression assays from Applied
Biosystems, Lifetechnologies, France) are listed in the supplemental table in
the online appendix available at http://diabetes.diabetesjournals.org.
Culture and treatment of SAT-EC. Senescence-associated--galactosidase
(SA--gal) activity was determined in human SAT-EC isolated from nonobese
healthy women (mean BMI  SEM  25.34  1.033, range 22.0–28.5; mean
age  SEM  48.5  3.074, range 35–57) and treated or not with adipocyte-
conditioned media from SAT and VAT (pretreated or not for 1 h with 1 g/ml
VEGFA neutralizing antibody [R&D systems, Lille, France], or with VEGFA [10
ng/ml; Peprotech, Levallois-Perret, France]). Cells were ﬁxed (5 min, room
temperature) in 0.5% glutaraldehyde, washed with PBS, and incubated at 37°C
for 16 h with fresh SA--gal staining solution (1 mg/ml of 5-bromo-4-chloro-
3-indolyl galactopyranoside in dimethylformamide) supplemented with 0.12
mmol/l potassium ferrocyanide, 0.12 mmol/l potassium ferricyanide, and 1
mmol/l MgCl2 (pH 6). The enzymatic reaction was stopped with water. Cells
TABLE 1
Human SAT and VAT adipocyte sizes
SAT (%  SE) VAT (%  SE) P
Adipocytes 60 m 29.1  3.6 33.8  3.0 0.12 ns
Adipocytes 	100 m 33.2  3.0 19.1  2.2 0.0003**
Data are percentages  SE of small ( 60 m) and large adipocytes
(100 m) in paired samples of SAT and VAT from n  30 subjects;
*P  0.05; **P  0.01; paired t test between SAT and VAT; ns, not
signiﬁcant.
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FIG. 1. Hypoxia-related genes in human SAT and VAT adipocytes. A:
Comparison of mature adipocyte gene expression in SAT and VAT (n 
30). Hypoxia inducible factor 1 or 2,  subunit (HIF-1, HIF-2),
GLUT1, vascular endothelial growth factor A (VEGFA), and fasting-
induced adipose factor (FIAF). Open bars: genes upregulated, and
solid bars: genes downregulated in VAT compared with SAT. Results
are expressed as fold differences between VAT and SAT as means 
SEM. *P < 0.05, **P < 0.01; paired t tests between SAT and VAT. B:
SAT adipocyte gene expression under normoxic (Nx) and hypoxic
conditions (1% O2)( n  6). Open bars: gene expression under
normoxic conditions, and solid bars: gene expression under hypoxic
conditions. Results are expressed as means  SEM **P < 0.01; paired
t tests between normoxic and hypoxic conditions.
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through scanning the whole well and normalized to the total number of cells
determined in four different ﬁelds with Hoescht 33342 nuclear staining using
NIS software.
Statistical analyses. Statistical analyses were performed with GraphPad
Software (San Diego, CA). Values are expressed as means  SEM of (n)
independent experiments. Correlations were determined with the Spearman
test. Comparisons between the two groups (paired biopsies from SAT and
VAT) were analyzed by paired Student t tests. Comparisons among groups
were made by one-way ANOVA followed by a Dunnett post hoc test.
Differences were considered signiﬁcant when P  0.05.
RESULTS
Adipocyte size and hypoxia-related gene expression
in human subcutaneous and visceral AT (SAT and
VAT). Human mature adipocytes were isolated from
paired biopsies of SAT and VAT from obese subjects.
Adipocytes were classiﬁed according to their diameter
(i.e., small, with a diameter less than 60 m; and large,
with a diameter more than 100 m) and the expression of
genes was analyzed by real-time PCR. The proportion of
large adipocytes was higher in SAT than VAT (Table 1).
Expression of hypoxia-related genes, such as hypoxia-
inducible factor (HIF)-1
, and certain HIF1-responsive
genes (vascular endothelial growth factor A [VEGFA] and
GLUT1, was higher in VAT than SAT adipocytes (Fig. 1A).
In contrast, other genes regulated by hypoxic conditions
and induced by HIF-1
, including leptin and the fasting-
induced adipose factor (FIAF), exhibited the inverse pro-
ﬁle (Fig. 1A). To further deﬁne the impact of hypoxia and
adipocyte size on adipocyte gene expression, correlations
among transcript levels and percentages of large adipo-
cytes were calculated. Adipocyte transcript levels of
VEGFA and GLUT1 were positively correlated with HIF1-

mRNA, irrespective of fat depot origin (*P  0.03; Spear-
man r  0.2425, n  60 [SAT and VAT]; and **P  0.0001;
Spearman r  0.4744, n  60 [SAT and VAT], respectively).
However, leptin and FIAF mRNAs were positively corre-
lated with the percentage of large adipocytes (*P  0.012;
Spearman r  0.3302, n  60 [SAT and VAT]; and *P 
0.014; Spearman r  0.3231, n  60 [SAT and VAT],
respectively). No correlation was found between the per-
centage of large adipocytes and transcript levels of HIF-
1
, GLUT1, or VEGFA. Finally, the speciﬁc impact of low
oxygen tension on adipocyte VEGFA and GLUT1 expres-
sion was conﬁrmed by real-time PCR analysis of mature
SAT adipocytes maintained in culture for 24 h under
normoxic or hypoxic (1% O2) conditions. VEGFA and
GLUT1 transcript levels were increased under hypoxic
culture conditions, whereas leptin and FIAF were not
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FIG. 2. Vascular network and EC number in human SAT and VAT. A and B: Representative photomicrographs of three-dimensional confocal
immunoﬂuorescence analyses of human (A) SAT and (B) VAT using antibodies directed against CD34 (green) and CD31 (red) (n  5). Original
magniﬁcation 10. C: Flow cytometry analyses were performed on freshly harvested SVF using ﬂuorescently-labeled antibodies directed against
CD34 and CD31 (n  30). Open bar: SAT, and solid bar: VAT. Results are means  SEM of the number of CD34
/CD31
 cells per gram of AT *P <
0.05; paired t tests between the two AT depots. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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cytes exhibit hypoxia-related characteristics, with increased
HIF-1
, VEGFA, and GLUT1 expression, independently of fat
cell size.
Vascular network and EC abundance in human SAT
and VAT. To test whether a less extensive vascular
network in VAT contributes to higher hypoxia-related gene
expression in VAT than SAT in obese subjects, SAT and
VAT were analyzed using three-dimensional confocal im-
munoﬂuorescence microscopy for the EC markers CD34
and CD31. The apparent density of the vascular network,
determined from colocalized CD34 and CD31 positive
signals, was greater in VAT than SAT (Fig. 2B and A,
respectively). This was conﬁrmed by ﬂow cytometry of
SVF from both depots. The number of CD34
/CD31
 cells,
normalized for tissue weight, was signiﬁcantly higher in
VAT than SAT (Fig. 2C). Thus, capillary density is higher in
human VAT than SAT in obese subjects. To note, the EC
number in SAT of lean (n  42) subjects was similar to
that of obese subjects (20,378  2,554 vs. 25,476  3,211
cells/g AT, respectively; P  0.1), indicating that growth of
SAT is associated with concomitant expansion of its
capillary network.
The EC phenotype of human SAT and VAT. To deter-
mine whether hypoxia-related gene expression in VAT
adipocytes is related to endothelial dysfunction, native
human CD34
/CD31
 cells were isolated by immunoselec-
tion/depletion from SAT and VAT from obese subjects in
biopsies that were of sufﬁcient size. Genes involved in
inﬂammation (chemokines and adhesion molecules), an-
giogenesis, metabolism, and cellular senescence were
analyzed by real-time PCR. Many of the genes encoding
proinﬂammatory and angiogenic factor receptors were
upregulated in VAT compared with SAT-EC, including CC
motif ligand 20 (CCL20), chemokine CXC motif ligand 8
(CXCL8), intercellular adhesion molecule-1 (ICAM1), vas-
cular endothelial growth factor receptor 2 (VEGFR2),
leptin receptor (Leptin R), and neuropilin 1 and neuropilin
2 (NRP1 and NRP2; Fig. 3A and B, respectively). Expres-
sion of genes involved in metabolism, such as endothelial
lipase (EL), LPL, PPAR, and GPIHBP1, tended to be
higher in SAT than VAT-EC, although differences for EL
and LPL did not reach statistical signiﬁcance (Fig. 3C).
Immunohistochemical analyses conﬁrmed the increased
expression of ICAM1 and decreased expression of
GPIHBP1 in EC from VAT compared with SAT in obese
subjects (Fig. 4B and C, and Fig. 4E and F, respectively).
To note, both proteins were expressed at similar levels in
SAT from lean and obese subjects (Fig. 4A and D).
Moreover, real-time PCR analyses performed on isolated
SAT-EC from lean subjects (n  6) did not differ substan-
tially in CCL20, CXCL8, ICAM1, Leptin R, NRP2, and EL
compared with obese SAT-EC (data not shown). Finally,
expression of the deacetylase, SIRT1, was decreased,
whereas insulin-like growth factor binding protein 3 (IG-
FBP3), a gene upregulated in senescent EC, was increased
in VAT-EC from obese subjects compared with SAT-EC
(Fig. 5A and B, respectively). No differences in SIRT1 and
IGFBP3 expression were detected in SAT-EC from lean
and obese subjects (data not shown). To test whether
cellular senescence is more extensive in VAT than SAT-
EC, immunoﬂuorescence analyses were performed using
an antibody directed against -H2AX, a marker of senes-
cent nuclei. We observed -H2AX positive nuclei in both
SAT and VAT (Fig. 5C and D, respectively), but at a higher
density in VAT-EC (3.3-fold increase in VAT vs. SAT, P 
0.0004, **n  10).
Effects of the SAT and VAT microenvironment on
senescence of human EC. To deﬁne effects of the SAT
and VAT microenvironments on EC, native SAT-EC from
nonobese women were treated with SAT and VAT adipo-
cyte-conditioned media. Adipocyte-conditioned media
clearly increased the number of SA--gal positive EC
compared with control basal medium (Fig. 6B and A,
respectively). Moreover, native SAT-EC treated with VAT
conditioned medium developed a signiﬁcantly higher per-
centage of senescent cells than the same native SAT-EC
cells treated with SAT-derived conditioned medium (Fig.
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FIG. 3. Expression of inﬂammatory, angiogenic, and metabolic genes in
human SAT and VAT EC. A–C: Comparison of SAT EC and VAT EC gene
expression. CC motif ligand 20 (CCL20), CC motif ligand 2 (CCL2),
chemokine CXC motif ligand 8 (CXCL8), platelet endothelial cell
adhesion molecule-1 (PECAM1), intercellular adhesion molecule-1
(ICAM1), vascular endothelial growth factor receptor 1 and vascular
endothelial growth factor receptor 2 (VEGFR1 and VEGFR2), leptin
receptor (Leptin R), neuropilin 1 and neuropilin 2 (NRP1 and NRP2),
endothelial lipase (EL), lipoprotein lipase (LPL), peroxisome prolif-
erator-activated receptor gamma (PPAR), and GPI-anchored HDL-
binding protein 1 (GPIHBP1). Open bars: genes upregulated, and solid
bars: genes downregulated in VAT compared with SAT. Results are
expressed as fold differences between VAT EC and SAT EC as means 
SEM (n  7 to 11) *P < 0.05, **P < 0.01; paired t tests between SAT EC
and VAT EC.
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SAT and VAT adipocyte-conditioned media, but to a
greater extent in VAT than SAT-EC (Fig. 6D). Finally, to
analyze the potential factor(s) involved in such a senes-
cence-promoting effect of adipocyte-conditioned media,
SAT-EC were treated with VEGFA alone or with SAT- and
VAT-derived conditioned media in the presence of neutral-
izing VEGFA antibody. Although VEGFA increased the
number of SA--gal positive EC, the presence of a neutral-
izing VEGFA antibody signiﬁcantly reduced the effects of
SAT- and VAT-conditioned media (Fig. 6C).
DISCUSSION
We found greater expression of hypoxia-related genes and
smaller sizes of VAT than SAT adipocytes in obese sub-
jects. The increased hypoxia in VAT is not likely to be a
consequence of capillary rarefaction since vascular den-
sity, as well as EC number, were higher in VAT than SAT.
However, the VAT-EC phenotype in obese subjects was
markedly proangiogenic and inﬂammatory, with de-
creased expression of metabolism-related genes, including
EL, GPIHBP1, and PPAR. This phenotype of VAT-EC in
obese subjects could be related to premature EC senes-
cence, as suggested by expression of the senescence
markers, IGFBP3 and -H2AX, as well as decreased ex-
pression of SIRT1.
AT is regionally distinct in terms of function, adipokine
production, and inﬂammation. Adipocytes from VAT ap-
pear to have reduced capacity for lipogenesis (17) and
greater capacity for lipolysis than SAT cells (15), with VAT
containing more proinﬂammatory immune cells than SAT
(12). In the present study and consistent with other reports
(18,19), marked hypertrophy of SAT compared with VAT
adipocytes was observed in obese subjects. Increased
SAT
Lean
SAT 
OB
VAT 
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ICAM1/CD34 GPIHBP1
A
B
C
D
E
F
FIG. 4. Expression of ICAM1 and GPIHBP1 proteins in SAT and VAT. Representative photomicrographs of immunoﬂuorescence analyses of
human SAT from lean subjects (n  4, 5) (A and D), obese subjects (n  6, 9) (B and E) and VAT from obese subjects (n  6, 9) (C, F) using
antibodies directed against ICAM1 (green) and CD34 (red) (A–C) GPIHBP1 (green) (D–F) with nuclear staining with Hoescht 33342 (blue).
Original magniﬁcation 40. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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, VEGFA,
and GLUT1 was found in VAT compared with SAT adipo-
cytes. Despite previous studies reporting that leptin and
FIAF are induced under hypoxic conditions (20,21), we
found they were lower in VAT than SAT. Irrespective of AT
location, both leptin and FIAF transcript levels correlated
with adipocyte size, as noted by others for leptin (22).
Expression of VEGFA and GLUT1 was tightly linked with
that of HIF-1
. Moreover, SAT adipocytes maintained
under low oxygen conditions had higher VEGFA and
GLUT1 expresssion than VAT, whereas the expression of
both leptin and FIAF was not affected substantially. To-
gether, the present results indicate that hypoxia-related
processes are more highly activated in VAT than SAT and
are not related to the extent of adipocyte hypertrophy in
obese subjects. Moreover, qualitative analyses by confocal
microscopy and ﬂow cytometry, using both the EC mark-
ers CD34 and CD31 simultaneously, reveal that capillary
network density was higher in VAT than in SAT. Therefore,
hypoxia in VAT is unlikely to be a consequence of capillary
rarefaction.
Treatment of native SAT-EC originating from normal
nonobese women with conditioned media originating from
VAT adipocytes from obese subjects led to marked prolif-
eration compared with conditioned media from SAT adi-
pocytes from the same subjects. This suggests that the
microenvironment of VAT is more proangiogenic than SAT
and is consistent with the greater capillary density in VAT
than SAT. Whether increased proangiogenic induction by
VAT adipocytes is related to hypoxia- and inﬂammation-
related events remains to be determined. Our results
indicate that VAT-EC from obese subjects exhibited a
markedly proinﬂammatory and angiogenic activated state,
with increased expression of chemokines, adhesion mol-
ecules, and angiogenic factor receptors. This phenotype
could contribute to the greater abundance of proinﬂam-
matory immune cells in VAT than SAT (12). EL and
GPIHBP1 are EC-speciﬁc metabolic genes, at least in
murine models (23). Together with PPAR (the main
regulator of GPIHBP1), these genes were downregulated
in VAT compared with SAT. A recent study in murine
models of diet-induced obesity highlighted the key role of
PPAR in the modulation of EC function and metabolic
alterations associated with obesity (7). Together our re-
sults show that although the capillary density of VAT is
higher than that of SAT, VAT-EC exhibit a phenotype
characterized by marked activation of inﬂammatory and
angiogenic pathways associated with altered metabolic
function in obese subjects.
This proangiogenic, proinﬂammatory phenotype might
be related to premature endothelial cellular senescence.
Indeed, senescent EC exhibit an activated state that may
by induced either by extensive cell replication, leading to
premature irreversible cell growth arrest, or by various
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FIG. 5. Markers of senescence in native EC in SAT and VAT. A–B: Expression of (A) sirtuin 1 (SIRT1, n  9) and (B) insulin-like growth factor
binding protein 3 (IGFBP3, n  11) in SAT EC and VAT EC. Open bars: SAT EC, and solid bars: VAT EC. Results are expressed as means  SEM;
*P < 0.05, **P < 0.01; paired t tests between SAT EC and VAT EC. C–D: Representative photomicrographs of immunohistoﬂuorescence analyses
of human (C) SAT and (D) VAT using antibody directed against phospho--H2AX (red) and nuclear staining (blue) with Hoescht 33342 (n  10).
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pression of SIRT1, together with increased expression of
IGFBP3 and -H2AX, have been noted in senescent, repli-
catively exhausted human EC (25–28), and we found
indications of cellular senescence found in VAT-EC from
obese subjects. Moreover, since conditioned media origi-
nating from VAT adipocytes increased the number of
SA--gal positive EC, it is tempting to speculate that the
chronic proangiogenic microenvironment of VAT pro-
motes premature EC senescence, leading to endothelial
dysfunction. Interestingly, VEGFA alone enhanced the
number of SA--gal positive EC, although to a lesser
extent than adipocyte-conditioned media. Moreover, neu-
tralization of VEGFA reduced the senescence-promoting
effect of the SAT and VAT adipocyte-conditioned media,
suggesting that VEGFA might be an adipocyte-derived
factor involved in premature adipose tissue EC senes-
cence, consistent with its effects on EC senescence in
other systems (29,30).
Cellular senescence in other cell types is associated
with a senescent secretory phenotype, with increased
production of proinﬂammatory cytokines, chemokines,
and extracellular matrix-modifying proteins, as well as
angiogenic factors (31–35). It will be important to deﬁne
the secreted protein proﬁle of senescent VAT-EC and
SAT-EC and to determine whether such a phenotype is
involved in the accumulation of immuno-inﬂammatory
cells. Consistent with this possibility, we previously
showed that treatment of SAT-EC with SAT adipocyte-
conditioned media led to increased diapedesis of blood-
derived monocytes (10).
The subjects in our study were obese. Whether regional
variation in fat tissue EC properties are already present in
lean subjects or arise as a consequence of obesity needs to
be determined. Since cellular senescence is increased in
obesity (36) and since obesity is associated with aortic
endothelial cell senescence (37), it is tempting to specu-
late that obesity could induce senescence in VAT-EC to a
greater extent than in SAT-EC. Consistent with this spec-
ulation, our study shows that SAT-EC from lean and obese
subjects did not exhibit marked phenotypic differences or
numbers relative to AT weight. If comparative studies of
VAT-EC from lean and obese subjects validate our specu-
lation, interventions that limit the accumulation of senes-
cent EC or their proinﬂammatory state could improve the
approaches to limit inﬂammation attributable to obesity
and its complications.
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